Annexon Inc (NAS:ANNX)
$ 5.39 0.05 (0.94%) Market Cap: 574.54 Mil Enterprise Value: 264.03 Mil PE Ratio: 0 PB Ratio: 1.72 GF Score: 40/100

Annexon Inc Annual Shareholders Meeting Transcript

Jun 02, 2021 / 04:00PM GMT
Release Date Price: $21.03 (-0.99%)
Operator

Welcome to the Annexon 2021 Annual Meeting of Stockholders. Mr. Love, you may now begin.

Douglas Love
Annexon, Inc. - President, CEO & Director

Thank You. Good morning. I'm Douglas Love, President and CEO of Annexon Biosciences. I'm very happy to welcome you to Annexon's 2021 annual meeting of stockholders. Here at Annexon, we've made significant progress toward our goal of building a leading complement company. And every day, we're sharply focused on advancing our mission to deliver transformative therapies for patients with complement-driven autoimmune and neurodegenerative diseases.

We are conducting our annual meeting virtually. Before I call the meeting to order, I'd like to introduce to you the members of the Board and the business team who are present online with us today. The members of the Board participating online today are Tom Wiggans, Chairman of the Board, William Carson, Jung Choi, Muneer Satter, [Britney Sterling] and myself, Douglas Love. The other members of the company's leadership team joining us online today are Ms. Jennifer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot